Back to search

Article

CBL mutations in pediatric solid and CNS tumors are a marker of receptor tyrosine kinase activation and a potential therapeutic target

2025-12-05

Abstract excerpt

Mutations in CBL , an E3 ubiquitin ligase that negatively regulates receptor tyrosine kinases (RTKs) and potentiates intracellular signaling, have been extensively characterized in hematological malignancies. However, the impacts are unknown in other cancer types. We have identified established and novel aberrations in CBL in molecularly diverse pediatric CNS and solid tumors. Additionally, we present novel CBL...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cce77d8f-a6da-5a16-98c5-5a2e919dc8f9
DOI
10.64898/2025.12.02.691063
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CBL mutations in pediatric solid and CNS tumors are a marker of receptor tyrosine kinase activation and a potential therapeutic targetDOI 10.64898/2025.12.02.691063
Select a neighboring publication to make it the new centre.